
Book Chapter: RNA Origami in Action ā Our Science Behind Helixomer's Technology
Abhichart Krissanaprasit
Monday, May 15, 2023
š Excited to share my latest publication as an author in the Springer Nature volume: RNA Nanotechnology and Therapeutics: Methods and Protocols
š Chapter 18: Production and Testing of RNA Origami Anticoagulants
Co-authored with Carson Key, Kristen Froehlich, and Thom LaBean
This chapter outlines detailed protocols for designing, producing, and evaluating RNA origami-based anticoagulants that use thrombin RNA aptamers. These programmable RNA nanostructures show promising therapeutic potential with high specificity, reversible activity, and improved pharmacokinetics ā foundational to the RNA origami platform we're building at Helixomer.
š¬ We explore how self-folding, single-stranded RNA origami can deliver superior anticoagulant effects compared to free aptamers or DNA nanostructures, including using 2ā²F-modified nucleotides, heat-annealing protocols, and aPTT assays for activity testing.
š Check out the chapter here:
š Springer Book Link
#RNAorigami #Anticoagulant #AptamerTherapeutics #Biotech #NucleicAcidNanotechnology #Helixomer #PrecisionMedicine #RNA
